Last reviewed · How we verify

NCT06706323: PCD

Depressive Symptoms After Cardiac Surgery

Recruiting now Last updated 1 April 2025
What this trial tests

trial in Cardiovascular Diseases in 300 participants. Currently enrolling.

Timeline
25 November 2024
Primary endpoint
1 April 2027
31 August 2027

Quick facts

Lead sponsorRoland von Känel
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date25 November 2024
Primary completion1 April 2027
Estimated completion31 August 2027
Sites2 locations across Switzerland

Conditions studied

Sponsor

Roland von Känel

Who can join

Adults 18 to 90, any sex, with Cardiovascular Diseases or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this project is to develop a predictive model for clinically significant depressive symptoms (CSDS) in patients undergoing coronary artery bypass graft (CABG) surgery, using pre- and perioperative data. CSDS occur in about 30 percent of CABG patients, which is four times higher than in the general population. These symptoms are linked to poor quality of life and increased morbidity and mortality. The aim is to create a model that can identify patients at risk for postoperative depression. This tool could help clinicians make informed decisions and take preventive measures to manage depression after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06706323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing